Grapheal logo — Bringing connectivity to biosensors. Digital biosensors for...

Grapheal

Bringing connectivity to biosensors. Digital biosensors for wearables, diagnostics and wound care.

Founded 2019 France France 8 employees Grant Total: $1.90M Biotechnology, Hardware +4

General Information

Company Name Grapheal
Founded Year 2019
Location France France
Employees 8
Industries Biotechnology, Hardware, Health Care +3
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Grapheal. To contact Grapheal, visit grapheal.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Grapheal compare?

A PDF of Grapheal and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Grapheal soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Grapheal

GRAPHEAL is a French biotechnology startup focused on bringing connectivity to biosensors, with a mission to develop digital biosensors for wearables, diagnostics, and wound care. Grapheal is a spin-off from Neel Institute at the French Research Center CNRS in Grenoble, founded in 2019. Leveraging 10 years of research and development on biomaterials fabrication and integration, Grapheal has emerged with the aim of improving chronic wounds medical care through a new generation of smart-bandages. The core technology of Grapheal is centered on the physical and biochemical properties of graphene. It utilizes graphene as a bioactive material, an electrical platform for wound stimulation, and a biodetection platform to monitor real-time healing. The company's smart-bandages offer benefits to both patients and medical staff, as they combine efficient and flexible dressing with a simple smartphone app for monitoring day-to-day wound healing progress. With strong footings in Biotechnology, Hardware, Health Care, IoT, Medical Devices, and Autonomous and Sensor Tech industries, Grapheal received a grant investment from Health Engine on 27 April 2023. This investment marks a significant milestone in the company's journey, strengthening its position in the burgeoning digital biosensors and healthcare technology landscape.

Business keywords: wearable technology, biosensors, medical assessment, continuous monitoring, individualized care, Grenoble, France, startup, personalized healthcare, diagnosis technology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
Health Engine
27 Apr 2023
Seed Round €1.90M 2
Bpifrance, Novalis Biotech
10 Feb 2021
Non Equity Assistance Undisclosed 1
MassChallenge
21 Oct 2020

Grapheal Alternatives & Competitors

View All Alternatives
Grapheal vs
MELLIsim
MELLIsim France

Diabetes care for Type 2

1 employees
Health Care, Medical Devices
Grapheal vs
PyrAmes
PyrAmes United States

Blood pressure monitoring reimagined

Series A
13 employees
Health Care, IT
Grapheal vs

Wireless, Continuous, Simple, Hemodynamic Monitoring at all points of care.

Series C
84 employees
Health Care, Medical Devices

FAQ About Grapheal

Bringing connectivity to biosensors. Digital biosensors for wearables, diagnostics and wound care.
Grapheal was founded in 2019.
Grapheal is headquartered in France.
Grapheal operates in Biotechnology, Hardware, Health Care, IoT, Medical Devices and Autonomous and Sensor Tech. Its work centres on wearable technology, biosensors, medical assessment and continuous monitoring.
Grapheal has approximately 8 employees.
Grapheal has completed 3 funding rounds, raising a total of $1.90M. The latest funding stage is Grant.
Top alternatives and competitors to Grapheal include MELLIsim, PyrAmes, Caretaker Medical | Wireless Hemodynamic Monitoring, Strados Labs, F2D Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Grapheal and MELLIsim are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Grapheal, https://bouncewatch.com/company/grapheal, updated 13 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes